2020
DOI: 10.1007/s11845-020-02237-z
|View full text |Cite
|
Sign up to set email alerts
|

A prospective feasibility study of MammoSite accelerated partial breast irradiation for early breast Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…83,84 Similar outcomes have been seen in smaller institutional series as well, with multilumen and strut applicators demonstrating the potential for improved toxicity profiles. [85][86][87][88][89][90] Outcomes for patients with ductal carcinoma in situ (DCIS) treated with applicator brachytherapy have been evaluated; although smaller studies suggested potentially increased rates of IBTR, the MammoSite Registry data demonstrated low rates of local recurrence in patients with DCIS. 84,91 Although traditionally delivered in 8 to 10 fractions over 4 to 5 days, shorter regimens with applicator brachytherapy have been evaluated.…”
Section: Ultrashort Partial Breast Irradiationmentioning
confidence: 99%
“…83,84 Similar outcomes have been seen in smaller institutional series as well, with multilumen and strut applicators demonstrating the potential for improved toxicity profiles. [85][86][87][88][89][90] Outcomes for patients with ductal carcinoma in situ (DCIS) treated with applicator brachytherapy have been evaluated; although smaller studies suggested potentially increased rates of IBTR, the MammoSite Registry data demonstrated low rates of local recurrence in patients with DCIS. 84,91 Although traditionally delivered in 8 to 10 fractions over 4 to 5 days, shorter regimens with applicator brachytherapy have been evaluated.…”
Section: Ultrashort Partial Breast Irradiationmentioning
confidence: 99%